These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 28836063)

  • 1. Prognostic significance of Fuhrman grade and age for cancer-specific and overall survival in patients with papillary renal cell carcinoma: results of an international multi-institutional study on 2189 patients.
    Borgmann H; Musquera M; Haferkamp A; Vilaseca A; Klatte T; Shariat SF; Scavuzzo A; Jimenez Rios MA; Wolff I; Capitanio U; Dell'Oglio P; Krabbe LM; Herrmann E; Ecke T; Vergho D; Huck N; Wagener N; Pahernik S; Zastrow S; Wirth M; Surcel C; Mirvald C; Prochazkova K; Hutterer G; Zigeuner R; Cindolo L; Hora M; Stief CG; May M; Brookman-May SD
    World J Urol; 2017 Dec; 35(12):1891-1897. PubMed ID: 28836063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery.
    Leibovich BC; Lohse CM; Cheville JC; Zaid HB; Boorjian SA; Frank I; Thompson RH; Parker WP
    Eur Urol; 2018 May; 73(5):772-780. PubMed ID: 29398265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic and discriminative power of the 7th TNM classification for patients with surgically treated papillary renal cell carcinoma: results of a multi-institutional validation study (CORONA subtype project).
    May M; Surcel C; Capitanio U; Dell'Oglio P; Klatte T; Shariat S; Ecke T; Wolff I; Vergho D; Wagener N; Huck N; Pahernik S; Zastrow S; Wirth M; Borgmann H; Haferkamp A; Musquera M; Krabbe LM; Herrmann E; Scavuzzo A; Mirvald C; Hutterer G; Zigeuner R; Stief CG; Waidelich R; Cindolo L; Kalusova K; Brookman-May SD;
    Scand J Urol; 2017 Aug; 51(4):269-276. PubMed ID: 28399699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
    Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
    Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical analysis of a simplified Fuhrman grading scheme for prediction of cancer specific mortality in patients with clear cell renal cell carcinoma--Impact on prognosis.
    Becker A; Hickmann D; Hansen J; Meyer C; Rink M; Schmid M; Eichelberg C; Strini K; Chromecki T; Jesche J; Regier M; Randazzo M; Tilki D; Ahyai S; Dahlem R; Fisch M; Zigeuner R; Chun FK
    Eur J Surg Oncol; 2016 Mar; 42(3):419-25. PubMed ID: 26520403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organ Preservation Is Less Frequently Performed in Women Surgically Treated for Papillary Renal Cell Carcinoma-Results of a Comprehensive Multicenter Study.
    Wolff I; Scavuzzo A; Capitanio U; Klatte T; Shariat SF; Wagener N; Zastrow S; Borgmann H; Krabbe LM; Hutterer G; May M; Brookman-May SD;
    Urology; 2017 Nov; 109():107-114. PubMed ID: 28802570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic implications of sarcomatoid and rhabdoid differentiation in patients with grade 4 renal cell carcinoma.
    Kara O; Maurice MJ; Zargar H; Malkoc E; Akca O; Andrade HS; Ramirez D; Caputo PA; Nelson RJ; Rini B; Kaouk JH
    Int Urol Nephrol; 2016 Aug; 48(8):1253-1260. PubMed ID: 27215555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic role of histomorphological subtyping in nonmetastatic papillary renal cell carcinoma after curative surgery: is subtype really irrelevant? A propensity score matching analysis of a multi-institutional real life data.
    Erdem S; Bertolo R; Campi R; Capitanio U; Amparore D; Anceschi U; Mir MC; Roussel E; Pavan N; Carbonara U; Kara O; Klatte T; Marchioni M; Pecoraro A; Muselaers S; Marandino L; Diana P; Borregales L; Palumbo C; Warren H; Wu Z; Calio A; Ciccarese C; Degirmenci E; Aydin R; Rebez G; Schips L; Simone G; Minervini A; Serni S; Ozcan F
    Urol Oncol; 2024 May; 42(5):163.e1-163.e13. PubMed ID: 38443238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Papillary renal cell carcinoma: correlation of tumor grade and histologic characteristics with clinical outcome.
    Cornejo KM; Dong F; Zhou AG; Wu CL; Young RH; Braaten K; Sadow PM; Nielsen GP; Oliva E
    Hum Pathol; 2015 Oct; 46(10):1411-7. PubMed ID: 26297250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microvascular and lymphovascular tumour invasion are associated with poor prognosis and metastatic spread in renal cell carcinoma: a validation study in clinical practice.
    Bedke J; Heide J; Ribback S; Rausch S; de Martino M; Scharpf M; Haitel A; Zimmermann U; Pechoel M; Alkhayyat H; Shariat SF; Dombrowski F; Stenzl A; Burchardt M; Klatte T; Kroeger N
    BJU Int; 2018 Jan; 121(1):84-92. PubMed ID: 28803448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53-expression in patients with renal cell carcinoma correlates with a higher probability of disease progression and increased cancer-specific mortality after surgery but does not enhance the predictive accuracy of robust outcome models.
    Morshaeuser L; May M; Burger M; Otto W; Hutterer GC; Pichler M; Klatte T; Wild P; Buser L; Brookman-May S
    Urol Oncol; 2018 Mar; 36(3):94.e15-94.e21. PubMed ID: 29221641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter Study of Controlling Nutritional Status (CONUT) Score as a Prognostic Factor in Patients With HIV-Related Renal Cell Carcinoma.
    Xue W; Zhang Y; Wang H; Zhang Y; Hu X
    Front Immunol; 2021; 12():778746. PubMed ID: 34917092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1-pT3a localized renal cell carcinoma in a comprehensive multicenter study of the CORONA project. Can we improve prognostic discrimination for patients with stage pT3a tumors?
    Brookman-May SD; May M; Wolff I; Zigeuner R; Hutterer GC; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Tubaro A; Coman I; Truss M; Dalpiaz O; Feciche B; Figenshau RS; Madison K; Sánchez-Chapado M; Santiago Martin Mdel C; Salzano L; Lotrecchiano G; Zastrow S; Wirth M; Sountoulides P; Shariat S; Waidelich R; Stief C; Gunia S; ;
    Eur Urol; 2015 May; 67(5):943-51. PubMed ID: 25684695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in a large multi-institutional series of papillary renal cell carcinoma.
    Zucchi A; Novara G; Costantini E; Antonelli A; Carini M; Carmignani G; Cosciani Cunico S; Fontana D; Longo N; Martignoni G; Minervini A; Mirone V; Porena M; Roscigno M; Schiavina R; Simeone C; Simonato A; Siracusano S; Terrone C; Ficarra V
    BJU Int; 2012 Apr; 109(8):1140-6. PubMed ID: 21871053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should patients with low-risk renal cell carcinoma be followed differently after nephron-sparing surgery vs radical nephrectomy?
    Abu-Ghanem Y; Powles T; Capitanio U; Beisland C; Järvinen P; Stewart GD; Gudmundsson E; Lam TBL; Marconi L; Fernandéz-Pello S; Nisen H; Meijer RP; Volpe A; Ljungberg B; Klatte T; Bensalah K; Dabestani S; Bex A
    BJU Int; 2021 Sep; 128(3):386-394. PubMed ID: 33794055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologic subtype impacts cancer-specific survival in patients with sarcomatoid-variant renal cell carcinoma treated surgically.
    Nguyen DP; Vilaseca A; Vertosick EA; Corradi RB; Touijer KA; Benfante NE; Sjoberg DD; Russo P
    World J Urol; 2016 Apr; 34(4):539-44. PubMed ID: 26215750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative epidural analgesia is not associated with increased survival from renal cell cancer, but overall survival may be improved: a retrospective chart review.
    Kovac E; Firoozbakhsh F; Zargar H; Fergany A; Elsharkawy H
    Can J Anaesth; 2017 Jul; 64(7):754-762. PubMed ID: 28417354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcome.
    Krejci KG; Blute ML; Cheville JC; Sebo TJ; Lohse CM; Zincke H
    Urology; 2003 Oct; 62(4):641-6. PubMed ID: 14550434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of the geriatric nutritional risk index in patients with non-metastatic clear cell renal cell carcinoma: a propensity score matching analysis.
    Zhou H; Lv D; Cui F; Qian Gong ; Li J; Wen J; Jia M; Kang Y; Rong Y; Zhang W; Shuang W
    Nutr J; 2024 Sep; 23(1):114. PubMed ID: 39342187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.